Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Flexible budgets empower you to adjust spending as circumstances shift, strengthening your overall planning and helping you stay on track toward financial goals.
21,409 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
The CLARITY Act fight over crypto ethics stalled as lawmakers clashed on enforcement and state powers, leaving invest...
When a global pharma giant drops $1 billion on a single tech, investors sit up. This move by Johnson Johnson Just Pai...
Explore how Jean Eric Salata leads EQT Group to build durable value across private equity and beyond. This article di...
When markets swing, consumer staples ETFs like XLP and VDC often shine. This guide breaks down fees, yield, diversifi...
A fresh inflation print has spooked traders and pulled down shares. This guide translates history into actionable ste...
A new poll in 2026 finds a rising minority of Gen Z workers would prefer a robot supervisor, challenging traditional ...
A quiet giant in the chip world could deliver a rare investment upside. This guide explains what makes taiwan semicon...
Retail investors often worry about when insiders will sell. This guide breaks down the precise timeline when insiders...
As markets swing in July 2026, the tax treatment of stock gains hinges on one simple rule: hold for more than a year ...
A Duke University professor warns that lidar sensors in America's self-driving fleets are vulnerable to spoofing and ...
With federal Medicaid work requirements looming, several states are pushing legislation to publicly name big employer...